Atjaunināt sīkdatņu piekrišanu

E-grāmata: Sourcebook for Clinical Research: A Practical Guide for Study Conduct

(Human Subjects Research regulatory expert), (Washington, D.C.-based executive with extensive healthcare oversight, regulatory, and finance experience)
  • Formāts: EPUB+DRM
  • Izdošanas datums: 01-Aug-2018
  • Izdevniecība: Academic Press Inc
  • Valoda: eng
  • ISBN-13: 9780128162439
Citas grāmatas par šo tēmu:
  • Formāts - EPUB+DRM
  • Cena: 101,19 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
  • Formāts: EPUB+DRM
  • Izdošanas datums: 01-Aug-2018
  • Izdevniecība: Academic Press Inc
  • Valoda: eng
  • ISBN-13: 9780128162439
Citas grāmatas par šo tēmu:

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

A clinical trial is complex, with numerous regulations, administrative processes, medical procedures, deadlines, and specific protocol instructions to follow. The Sourcebook for Clinical Trials provides a comprehensive overview of the clinical trial process covering the basics to more advances topics. The book discusses foundational elements defining clinical trials and types of research studies, research personnel and responsibilities, and understanding the role of HIPAA and PHI. The book also covers pre-trial preparation and regulatory requirements, subject recruitment, mechanics and trial conduct, review boards and agencies involved in the clinical trial process as well as post-trial study closeout. The inclusion of helpful resources, sample forms, and checklists make The Sourcebook for Clinical Trials an essential step-by-step resource for those involved in conducting, managing, or overseeing clinical trials.

  • Offers guidance that is crucial for guaranteeing compliance to clinical trial protocols during each stage of the clinical trial process
  • Lays out vital information in an easy, accessible format to keep investigative teams current on federal regulations and good clinical practice
  • Provides up-to-date and extensive coverage of Federal and IRB regulations and helpful worksheets, templates, checklists, and protocol resources for clinical trial personnel to utilize
About the Authors xi
Preface xiii
ICONS for The Sourcebook for Clinical Research: A Practical Guide for Study Conduct xv
Chapter 1 Foundational Elements and Regulatory Requirements
1(30)
1.1 What is the Purpose of Medical Research?
1(1)
1.2 Defining the Types of Research Studies
2(8)
1.3 Mandatory Regulations and ICH GCP (International Council for Harmonisation Good Clinical Practice) Ethical Guidelines
10(6)
1.4 How to Secure a Clinical Trial and How to Market Your Medical Facility to Sponsors
16(2)
1.5 Principal Investigator (PI) Responsibilities
18(6)
1.6 Research Coordinator (RC) Responsibilities
24(2)
1.7 Understanding the Role of HIPAA and PHI in Clinical Research
26(5)
Endnotes
28(3)
Chapter 2 Preparation Before a Clinical Trial Begins
31(58)
2.1 Clinical Trial Feasibility Analysis
31(1)
2.2 Financial Conflict of Interest Regulations in a Clinical Trial
32(3)
2.3 Confidentiality Disclosure Agreement (Also Known as a Non-Disclosure Agreement)
35(1)
2.4 The Clinical Trial Contract (Also Known as a Clinical Services Agreement/CSA or a Clinical Trial Agreement/CTA)
36(3)
2.5 Consent Forms and Documentation
39(23)
2.5.1 Waiver or Alteration of Consent
55(2)
2.5.2 Waiver of Documentation of Consent
57(1)
2.5.3 Short Form Consent
58(2)
2.5.4 Assent
60(2)
2.6 The Clinical Trial Budget
62(8)
2.7 Study Start-Up and Sponsor Documentation Requirements
70(1)
2.8 The Medicare Coverage Analysis
71(9)
2.9 How to Register a Clinical Trial at www.ClinicalTrials.gov
80(5)
2.10 Flowchart for Sequence/Timing of All Tasks in This
Chapter
85(4)
Endnotes
87(2)
Chapter 3 Recruiting Clinical Research Subjects
89(14)
3.1 Activities Preparatory to Research: Identifying and/or Contacting Subjects for Study Recruitment
89(3)
3.2 Introduction to Recruiting Subjects for a Clinical Study
92(2)
3.2.1 Methods for Recruiting Subjects Internally
93(1)
3.3 Methods for Recruiting Subjects Externally
94(2)
3.4 External Subject Recruiting Strategies Involving Direct Media
96(4)
3.5 FDA Guidance Governing Direct Advertising
100(3)
Endnotes
101(2)
Chapter 4 Clinical Trial Conduct--A Daily Perspective
103(38)
4.1 HIPAA (Health Insurance Portability and Accountability Act) and De-Identified Chart Reviews and Databases
103(3)
4.2 Translation and Interpretation
106(3)
4.3 Blinding and Unblinding in a Clinical Trial
109(2)
4.4 Adverse Events and Reporting in a Clinical Trial
111(4)
4.5 The Various Forms Used in a Clinical Trial
115(16)
4.5.1 Delegation of Authority (DOA)/Delegation of Responsibility
129(2)
4.6 Project Management for Clinical Trials
131(4)
4.7 Coding for Clinical Trial Claims
135(3)
4.8 Choosing a CTMS
138(3)
Endnotes
139(2)
Chapter 5 Organizations With Oversight Responsibility in Clinical Research
141(12)
5.1 The Institutional Review Board
141(1)
5.2 The Central Institutional Review Board
142(1)
5.3 Data Safety Monitoring Board, Also Known as the Data Monitoring Committee
143(1)
5.4 Clinical Endpoint Committee
144(1)
5.5 Association for the Accreditation of Human Research Protection Programs, Inc
144(1)
5.6 What You Need to Know About FDA Inspections, Compliance, & Enforcement
144(9)
Endnotes
152(1)
Chapter 6 Exceptional Circumstances in Clinical Research
153(38)
6.1 Expanded Access (Compassionate Use)
153(4)
6.2 Charging for an Investigational New Drug in a Clinical Trial
157(3)
6.3 Emergency Use of a Test Article
160(4)
6.4 Research on Decedents and PHI in Clinical Research
164(1)
6.5 Vulnerable Populations
165(4)
6.6 Legally Authorized Representative and Witness
169(9)
6.7 What to do When a PI Departs From a Study or Institution
178(6)
6.8 Consequences of Clinical Research Non-Compliance and How to Respond to Non-Compliance
184(7)
Endnotes
189(2)
Chapter 7 Education and Certification in Clinical Research
191(10)
7.1 Bachelors and Masters Degree Programs in Clinical Research
191(5)
7.2 Certification Organizations
196(1)
7.3 Training Requirements for Personnel Conducting Clinical Trials
197(4)
Chapter 8 The Newest Changes in Clinical Research
201(26)
8.1 Human Subjects Protection: Acceptance of Data From Clinical Investigations for Medical Devices
201(1)
8.2 The New Common Rule
202(7)
8.3 Payment and Reimbursement to Research Subjects
209(1)
8.4 The Single Institutional Review Board (sIRB)
209(2)
8.5 New Changes to Certificates of Confidentiality
211(2)
8.6 New ICH GCP E6 R2 (Revision 2) Guidelines
213(6)
8.7 Electronic Common Technical Document (eCTD)
219(1)
8.8 New Changes in ClincialTrials.gov Registration and Reporting
219(8)
Endnotes
225(2)
Chapter 9 After the Study Has Ended
227(8)
9.1 Study Closeout
227(3)
9.2 Essential Documents and Regulations for Document Retention in Clinical Research
230(2)
9.3 Publishing the Results of a Clinical Research Study
232(3)
Endnotes
234(1)
Clinical Trials Glossary 235(20)
Index 255
Jeff Nelligan, J.D., is a Washington, D.C.-based executive with extensive healthcare oversight, regulatory, and finance experience in three Federal Cabinet Agencies and in the Legislative branch, including: as a Director at the Centers for Medicare and Medicaid Services (CMS) within the U.S. Department of Health and Human Services; as a Managing Director at the U.S. Government Accountability Office (GAO); and, as a senior staffer for three Members of Congress in the U.S. Senate and the U.S. House of Representatives. He is a graduate of Williams College and Georgetown University Law Center. Natasha Martien, MBA, CCRP, SSBBP, CRCP, is a Human Subjects Research regulatory expert with 25 years of clinical research and healthcare management experience at institutes including Johns Hopkins Hospital, The Center for Cardiac and Vascular Research, and Scripps Clinic and Research Foundation. Martien has performed every operational role in clinical research at sites, including: training IRB members, Investigators and Research Coordinators; regulatory management; working for Naan Office of Human Research Protections supporting an IRB; Research Coordination; writing and negotiating clinical trial agreements and budgets; financial management and billing; Coverage Analysis; CTMS acquisition; data analysis; credentialing; Quality Assurance; writing consent forms and study materials; compliance; advertising and recruiting; and the creation of a Clinical Trials Office. Martien has conducted and managed Investigator Initiated, Industry and Grant funded studies in 24 medical disciplines and for all study types, such as INDs, IDEs, biologics, stem cells, behavioral, pilot, observational, chart reviews and clinical trial Phases I through IV.